Guardant Health, Inc.
GH
$129.69
-$3.53-2.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.25% | 6.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.25% | 6.06% | |||
| Cost of Revenue | 5.45% | 6.31% | |||
| Gross Profit | 8.24% | 5.92% | |||
| SG&A Expenses | 11.19% | 13.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.24% | 10.41% | |||
| Operating Income | -0.55% | -22.06% | |||
| Income Before Tax | 14.22% | -40.64% | |||
| Income Tax Expenses | 121.54% | -1,369.85% | |||
| Earnings from Continuing Operations | 12.78% | -38.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.78% | -38.58% | |||
| EBIT | -0.55% | -22.06% | |||
| EBITDA | -1.15% | -23.67% | |||
| EPS Basic | 14.51% | -34.43% | |||
| Normalized Basic EPS | 6.06% | -22.24% | |||
| EPS Diluted | 14.51% | -34.43% | |||
| Normalized Diluted EPS | 6.06% | -22.24% | |||
| Average Basic Shares Outstanding | 2.03% | 3.08% | |||
| Average Diluted Shares Outstanding | 2.03% | 3.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||